These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 10938433)
21. [High dosage haloperidol reduces cataleptic response with increased noradrenaline metabolism in the rat brain areas]. Takashima M; Toru M Yakubutsu Seishin Kodo; 1983 Dec; 3(3):149-58. PubMed ID: 6687201 [TBL] [Abstract][Full Text] [Related]
22. CB1 cannabinoid receptor-mediated anandamide signaling mechanisms of the inferior colliculus modulate the haloperidol-induced catalepsy. Medeiros P; de Freitas RL; Silva MO; Coimbra NC; Melo-Thomas L Neuroscience; 2016 Nov; 337():17-26. PubMed ID: 27595886 [TBL] [Abstract][Full Text] [Related]
23. Influence of aversive stimulation on haloperidol-induced catalepsy in rats. Barroca NCB; Guarda MD; da Silva NT; Colombo AC; Reimer AE; Brandão ML; de Oliveira AR Behav Pharmacol; 2019 Apr; 30(2 and 3-Spec Issue):229-238. PubMed ID: 30632994 [TBL] [Abstract][Full Text] [Related]
24. Intensification of cataleptic response in 6-hydroxydopamine-induced neurodegeneration of substantia nigra is not dependent on the degree of dopamine depletion. Srinivasan J; Schmidt WJ Synapse; 2004 Mar; 51(3):213-8. PubMed ID: 14666519 [TBL] [Abstract][Full Text] [Related]
25. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol. Andersen HL; Kilpatrick IC Br J Pharmacol; 1996 May; 118(2):421-7. PubMed ID: 8735647 [TBL] [Abstract][Full Text] [Related]
26. SCH 58261, a selective adenosine A2A receptor antagonist, decreases the haloperidol-enhanced proenkephalin mRNA expression in the rat striatum. Wardas J; Pietraszek M; Dziedzicka-Wasylewska M Brain Res; 2003 Jul; 977(2):270-7. PubMed ID: 12834887 [TBL] [Abstract][Full Text] [Related]
28. Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol. Yanahashi S; Hashimoto K; Hattori K; Yuasa S; Iyo M Brain Res; 2004 Jun; 1011(1):84-93. PubMed ID: 15140647 [TBL] [Abstract][Full Text] [Related]
29. [Effect of haloperidol on changes in development of spontaneous catalepsy during subchronic injections of dopamine agonists and antagonists]. Kozlovskiĭ VL Patol Fiziol Eksp Ter; 2012; (3):75-80. PubMed ID: 23072116 [TBL] [Abstract][Full Text] [Related]
30. Effects of L-dopa and bromocriptine on haloperidol-induced motor deficits in mice. Kobayashi T; Araki T; Itoyama Y; Takeshita M; Ohta T; Oshima Y Life Sci; 1997; 61(26):2529-38. PubMed ID: 9416775 [TBL] [Abstract][Full Text] [Related]
31. Alteration of cataleptic responses induced by dopamine receptor antagonists after chronic cocaine administration in mice. Ushijima I; Mizuki Y; Yamada M Eur J Pharmacol; 1995 Oct; 285(1):55-9. PubMed ID: 8846811 [TBL] [Abstract][Full Text] [Related]
32. Enhanced striatal dopamine D(2) receptor-induced [35S]GTPgammaS binding after haloperidol treatment. Geurts M; Hermans E; Maloteaux JM Eur J Pharmacol; 1999 Oct; 382(2):119-27. PubMed ID: 10528146 [TBL] [Abstract][Full Text] [Related]
33. Conditioned catalepsy vs. Increase in locomotor activity induced by haloperidol. De la Casa LG; Cintado MA; González-Tirado G; Cárcel L Neurosci Lett; 2023 Apr; 802():137174. PubMed ID: 36906082 [TBL] [Abstract][Full Text] [Related]
34. Dosing time-dependent tolerance of catalepsy by repetitive administration of haloperidol in mice. Viyoch J; Ohdo S; Yukawa E; Higuchi S J Pharmacol Exp Ther; 2001 Sep; 298(3):964-9. PubMed ID: 11504791 [TBL] [Abstract][Full Text] [Related]
35. The PDE10A inhibitor MP-10 and haloperidol produce distinct gene expression profiles in the striatum and influence cataleptic behavior in rodents. Gentzel RC; Toolan D; Roberts R; Koser AJ; Kandebo M; Hershey J; Renger JJ; Uslaner J; Smith SM Neuropharmacology; 2015 Dec; 99():256-63. PubMed ID: 26044638 [TBL] [Abstract][Full Text] [Related]
36. Haloperidol-induced catalepsy is influenced by adenosine receptor antagonists. Malec D Pol J Pharmacol; 1997; 49(5):323-7. PubMed ID: 9566031 [TBL] [Abstract][Full Text] [Related]
37. D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors. Davidkova G; Zhou LW; Morabito M; Zhang SP; Weiss B J Pharmacol Exp Ther; 1998 Jun; 285(3):1187-96. PubMed ID: 9618422 [TBL] [Abstract][Full Text] [Related]
38. The effect of serotonergic agents on haloperidol-induced catalepsy. Hicks PB Life Sci; 1990; 47(18):1609-15. PubMed ID: 2250574 [TBL] [Abstract][Full Text] [Related]
39. Increase of spiny I activity in striatum after development of context-dependent sensitization of catalepsy in rats. Frank ST; Schmidt WJ Neurosci Lett; 2004 Jan; 354(1):10-3. PubMed ID: 14698470 [TBL] [Abstract][Full Text] [Related]